Clinical trial · Observational
Correlative Study on Cancer Patients and Healthcare Professionals Exposed to Infection by Severe Acute Respiratory Syndrome-Corona Virus-2 (SARS-Cov-2), COVID-19 Causative Agent.
Correlative Study on Cancer Patients and Healthcare Professionals Exposed to SARS-CoV-2 Infection
NCT04345315CI-TRIAL-00044680CORSAunknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Translational, prospective / retrospective, non-profit, non-pharmacological study, with cohort characteristics. The study consists of two parts: the first to study epidemiological aspects of the spread of the disease and the second one to identify infection-related genetic factors.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| COVID-19 | — | UNRESOLVED | — |
| SARS-CoV-2 | — | UNRESOLVED | — |
Interventions
Interventions (4)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Next generation Sequencing (NGS) analysis | Genetic | — | UNRESOLVED |
| Rapid molecular test | Other | — | UNRESOLVED |
| serological test | Other | — | UNRESOLVED |
| serum chemistry analysis | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- asymptomatic population at high risk of infection
- description
- healthy individuals at high risk of infection, including individuals who have had contact with a patient tested positive for COVID-19, voluntary health workers and oncological patients candidate to immunosuppressive therapy
- interventionNames
- Other: serological test
- Other: Rapid molecular test
- Other: serum chemistry analysis
- label
- COVID-19 patients
- description
- patients with confirmed diagnosis of COVID-19
- interventionNames
- Genetic: Next generation Sequencing (NGS) analysis
Primary outcomes (1)
- measure
- epidemiology
- timeFrame
- 12 months
- description
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
For epidemiologic analysis: Inclusion Criteria: * Age \> 18 years * asymptomatic * One of the following three conditions: • Healthy subjects who have had contact with COVID-19 positive patients • Healthcare workers • oncological patients candidates for cytotoxic chemotherapy at myeloablative doses (such as transplants) or treated with immune-check point inhibitors. * informed consent to the study and processing of data Exclusion Criteria: * presence of symptoms for COronaVIrus Disease 19 (COVID-19) (fever \> 37.5 °, cough, shortness of breath) For analysis of viral/host genetic factors involved in susceptibility/resistance to infection, samples from patients with confirmed diagnosis of COVID-19, residual from diagnostic procedures will be analyzed. All samples for genetic analysis will be anonymized.
References
Publications (0)
Data not yet available
No reference posted for this study.